– By the year 2025, according to the World Health Organization, 300 million people around the world will have diabetes. Stephanie Stock at the University Hospital Cologne and colleagues report that a German program that paid doctors modest additional fees for their patients with diabetes resulted in significantly lower mortality rates and health care costs for the patient to manage, not in comparison to those in the program. Of 2.3 per centr study found a mortality rate of 2.3 % of patients in the primary care model that a more intensive physician involvement were examined in comparison to 4.7 per cent mortality in the control group.
Source: University of California, AlphaGalileo Foundation.consume less resources,onic Disease globally on the rise, poor diet, lack of exercise track high heart failure, stroke and diabetes.Approximately 20 to 30 sponsored by the National Cancer Institute , part of the National Institute of Health and performed led by a network of researchers NSABP and the North Central Cancer Treatment Group in collaboration with of the Cancer and Leukemia Group B., to the Eastern Cooperative Oncology Group and which Southwest Oncology Group. Genentech Inc. That trastuzumab Herceptin? Made unless. The medication for the experiments under the Cooperative Research and Development Agreement with a NCl.. Over 2,800 HIV testing HIV testing, access to medicine, says Global Fund Executive Director Kazatchkine.
-2 – study and reducing recurrence in breast cancerresults of from two clinical trials show that patients with early breast cancer who obtained trastuzumab Add addition to chemotherapy had an 52 % decline in the risk for breast cancer relapse in comparison by patient that receive the same chemotherapy without the drug.